IL-17 and IL-22 Are Associated with Protection Against Human Kala Azar Caused by Leishmania Donovani

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2009 Jul 22

PMID 19620772

Citations 119

Authors

Maira G R Pitta

Audrey Romano

Sandrine Cabantous

Sandrine Henri

Awad Hammad

Bourema Kouriba

Laurent Argiro

Musa el Kheir

Bruno Bucheton

Charles Mary

Sayda Hassan El-Safi

Alain Dessein

Affiliations

Soon will be listed here.

Abstract

IL-17 and IL-22 have been shown to increase protection against certain bacteria and fungal pathogens in experimental models. However, no human studies have demonstrated a crucial role of IL-17 and IL-22 in protection against infections. We show here that Leishmania donovani, which can cause the lethal visceral disease Kala Azar (KA), stimulates the differentiation of Th17 cells, which produce IL-17, IL-22, and IFN-gamma. Analysis of Th1, Th2, and Th17 cytokine responses by cultured PBMCs from individuals in a cohort of subjects who developed KA or were protected against KA during a severe outbreak showed that IL-17 and IL-22 were strongly and independently associated with protection against KA. Our results suggest that, along with Th1 cytokines, IL-17 and IL-22 play complementary roles in human protection against KA, and that a defect in Th17 induction may increase the risk of KA.

Citing Articles

The development and maintenance of immunity against visceral leishmaniasis.

Tiwari R, Kumar A, Singh V, Rajneesh , Bhushan Chauhan S, Sundar S Front Immunol. 2025; 15:1486407.

PMID: 39781380 PMC: 11707418. DOI: 10.3389/fimmu.2024.1486407.

Application of the Sponge Model Implants in the Study of Vaccine Memory in Mice Previously Immunized with LBSap.

Lanna M, Resende L, De Luca P, Goes W, Zaldivar M, Costa A Vaccines (Basel). 2025; 12(12.

PMID: 39771984 PMC: 11680354. DOI: 10.3390/vaccines12121322.

Chemokines Signature and T Cell Dynamics in Leishmaniasis: Molecular insight and therapeutic application.

Upadhyay S, Kumar S, Singh V, Tiwari R, Kumar A, Sundar S Expert Rev Mol Med. 2024; 1-55.

PMID: 39587036 PMC: 11707835. DOI: 10.1017/erm.2024.36.

Immune response to viscerotropic : a comprehensive review.

Lodi L, Voarino M, Stocco S, Ricci S, Azzari C, Galli L Front Immunol. 2024; 15:1402539.

PMID: 39359727 PMC: 11445144. DOI: 10.3389/fimmu.2024.1402539.

Cytokine profiles, blood parasite load and clinical features of visceral leishmaniasis in West Pokot County, Kenya.

van Dijk N, Carter J, Kiptanui D, Pinelli E, Schallig H Parasitology. 2024; 151(7):753-761.

PMID: 39311405 PMC: 11474019. DOI: 10.1017/S0031182024000751.

References

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

Yen D, Cheung J, Scheerens H, Poulet F, Mcclanahan T, McKenzie B . IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006; 116(5):1310-6. PMC: 1451201. DOI: 10.1172/JCI21404. View

Lima G, Vallochi A, Silva U, BEVILACQUA E, Kiffer M, Abrahamsohn I . The role of polymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis. Immunol Lett. 1998; 64(2-3):145-51. DOI: 10.1016/s0165-2478(98)00099-6. View

McFarlane E, Perez C, Charmoy M, Allenbach C, Christine Carter K, Alexander J . Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun. 2007; 76(2):532-41. PMC: 2223441. DOI: 10.1128/IAI.01388-07. View

Stager S, Maroof A, Zubairi S, Sanos S, Kopf M, Kaye P . Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur J Immunol. 2006; 36(7):1764-71. PMC: 2659577. DOI: 10.1002/eji.200635937. View

Scriba T, Kalsdorf B, Abrahams D, Isaacs F, Hofmeister J, Black G . Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol. 2008; 180(3):1962-70. PMC: 2219462. DOI: 10.4049/jimmunol.180.3.1962. View

Ansari N, Saluja S, Salotra P . Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin Immunol. 2006; 119(3):339-45. DOI: 10.1016/j.clim.2006.01.017. View

Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y . Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol. 2007; 178(7):4466-72. DOI: 10.4049/jimmunol.178.7.4466. View

Sonderegger I, Kisielow J, Meier R, King C, Kopf M . IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol. 2008; 38(7):1833-8. DOI: 10.1002/eji.200838511. View

10.

Ivanov I, McKenzie B, Zhou L, Tadokoro C, Lepelley A, Lafaille J . The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006; 126(6):1121-33. DOI: 10.1016/j.cell.2006.07.035. View

11.

Dong C . TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008; 8(5):337-48. DOI: 10.1038/nri2295. View

12.

Locksley R, Pingel S, Lacy D, Wakil A, Bix M, Fowell D . Susceptibility to infectious diseases: Leishmania as a paradigm. J Infect Dis. 1999; 179 Suppl 2:S305-8. DOI: 10.1086/513843. View

13.

Coquet J, Chakravarti S, Smyth M, Godfrey D . Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol. 2008; 180(11):7097-101. DOI: 10.4049/jimmunol.180.11.7097. View

14.

Zheng Y, Valdez P, Danilenko D, Hu Y, Sa S, Gong Q . Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008; 14(3):282-9. DOI: 10.1038/nm1720. View

15.

Hailu A, Menon J, Berhe N, Gedamu L, Hassard T, Kager P . Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure. J Infect Dis. 2001; 184(1):112-5. DOI: 10.1086/320994. View

16.

Zenewicz L, Yancopoulos G, Valenzuela D, Murphy A, Karow M, Flavell R . Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity. 2007; 27(4):647-59. PMC: 2149911. DOI: 10.1016/j.immuni.2007.07.023. View

17.

von Stebut E . Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol. 2007; 17(2):115-22. DOI: 10.1684/ejd.2007.0122. View

18.

Langrish C, Chen Y, Blumenschein W, Mattson J, Basham B, Sedgwick J . IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005; 201(2):233-40. PMC: 2212798. DOI: 10.1084/jem.20041257. View

19.

Higgins S, Jarnicki A, Lavelle E, Mills K . TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol. 2006; 177(11):7980-9. DOI: 10.4049/jimmunol.177.11.7980. View

20.

El-Safi S, Bucheton B, Kheir M, Musa H, Hammad A, Dessein A . Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997). Microbes Infect. 2002; 4(14):1439-47. DOI: 10.1016/s1286-4579(02)00026-6. View